Strides Arcolab has received the US health regulator’s approval for the launch of Levofloxacin injections, an antibiotic, in the American market.The company has received approval from the US Food and Drug Administration (USFDA) for Levofloxacin injections in strengths of 25 mg/ml, packaged in 500mg/20 ml and 750mg/30 ml single-use vials, Strides Arcolab.
According to data from international drug research agency IMS for September, 2010, the total market for Levoflaxacin in the US is nearly $158 million, of which $5.68 million is for vials and the rest of the market is for bags.
Levofloxacin is a synthetic fluoroquinolone antibiotic used to treat mild to severe bacterial infections or bacterial infections that have failed to respond to other antibiotic classes. The infections that can be treated include respiratory tract infections, cellulitis, urinary tract infections, prostatitis, anthrax, endocarditis, meningitis, pelvic inflammatory disease and traveller’s diarrhea.crackcrack
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.55 |
| Dr. Reddys Lab | 1280.70 |
| Cipla | 1342.45 |
| Zydus Lifesciences | 935.75 |
| Lupin | 2251.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: